Medesthetics

NOV-DEC 2013

MedEsthetics—business education for medical practitioners—provides the latest noninvasive cosmetic procedures, treatment trends, product and equipment reviews, legal issues and medical aesthetics industry news.

Issue link: https://medesthetics.epubxp.com/i/197556

Contents of this Issue

Navigation

Page 74 of 78

MedEsthetics NEWS & EVENTS PUBLISHER/CEO Deborah Carver • dcarver@creativeage.com VICE PRESIDENT/CFO Mindy Rosiejka • mrosiejka@creativeage.com EDITORIAL DIRECTOR Stephanie Yaggy • syaggy@creativeage.com EDITORIAL EXECUTIVE EDITOR/ASSOCIATE PUBLISHER Inga Hansen • ihansen@creativeage.com ASSOCIATE EDITOR • Brandon Lowrey CONTRIBUTING EDITOR • Linda W. Lewis ART CREATIVE DIRECTOR • Dawn Cobalt ART DIRECTOR • Melody Ostil mostil@creativeage.com PHOTO EDITOR • Armando Sanchez PREPRESS MANAGER • Cam Campanaro DESKTOP SPECIALIST • Sophia Freeman ADVERTISING ASSOCIATE PUBLISHER/ADVERTISING DIRECTOR Lisa Fisco • lfisco@creativeage.com ACCOUNT EXECUTIVES Diane Jones • djones@creativeage.com Nazli Santana • nsantana@creativeage.com WEB/MARKETING MARKETING COORDINATOR • Andrew B. Smith WEB ART/UX DIRECTOR • Ryan Boydstun ASSOCIATE WEB EDITOR • Chrisi Talyn Saje CIRCULATION/PRODUCTION CIRCULATION DIRECTOR • Barbara Shepherd PRODUCTION DIRECTOR • Garnet Blair PRODUCTION MANAGER • Madlen Martinez PRODUCTION ASSISTANTS Claudia Marquez, Flora Robinson ADMINISTRATION ACCOUNTING MANAGER • Lourdes R. Nuno ACCOUNTS RECEIVABLE MANAGER Viktoriya Milshteyn ACCOUNTING ASSISTANT • Suzie Chavez SPECIAL PROJECTS MANAGER • Denise Maiman ADMINISTRATIVE ASSISTANT • Dario Dicochea Surgical Aesthetics Questions about your subscription? Contact MedEsthetics, Attn: Subscriptions, PO Box 1072, Skokie, IL. 60076-9712; 800.624.4196; medesthtics@halldata.com Publication Offices: MedEsthetics, 7628 Densmore Ave, Van Nuys, CA 91406-2042. For other questions call 818.782.7328 or fax 818.782.7450. The views and opinions printed herein are not to be taken as official expressions of the publishers, unless so stated. The publishers do not warrant, either expressly or by implication, the factual accuracy of the articles herein, nor do they so warrant any views or opinions offered by the authors of said articles. No part of this publication may be reproduced in any form or by any means, including photocopying, or utilized by any information storage and retrieval system without written permission from MedEsthetics. Copyright 2013 by Creative Age. All rights reserved. 70 NOVEMBER/DECEMBER 2013 | MedEsthetics markets and to expand into new areas with the best specialty-specific EMR system for doctors." NOVAN AWARDED $7.8 MILLION CONTRACT TO DEVELOP THERMAL BURN TREATMENT The U.S. Department of Health and Human Services has entered into a contract with Novan Therapeutics (novantherapeutics. com) to advance the development of a nitric oxide-based therapy as a countermeasure to treat thermal burns caused by a bioterrorism attack or nuclear device. The Biomedical Advanced Research and Development Authority (BARDA), an agency within the Office of the Assistant Secretary for Preparedness and Response, will provide funding of $7.8 million over two years. The contract will support the pharmaceutical development of the Nitric Oxide Advanced Healing (NOAH) technology including formulation work, nonclinical toxicology, and proof of concept studies in models of deep partial thickness and full thickness thermal injuries. Nitric oxide has been demonstrated throughout peer-reviewed literature to speed the migration of epidermal cells, stimulate new blood vessel growth, modulate inflammation, and re-model the wound bed. "The link between nitric oxide and the body's ability to heal is well established. The challenge is to create stable nitric oxide drugs that 'perform on command' and deliver a controlled, sustained dose that will supplement the body's ability to regenerate tissue," said Nathan Stasko, PhD, president of Novan. "Our platform technology has allowed us to pursue the development of drugs intended to harness the healing power of nitric oxide with results extending far beyond bioterrorism. We believe the NOAH technology creates a gateway into regenerative medicine and could lead to therapies that can help heal both acute and chronic wounds." LE MIEUX LAUNCHES BIELLE INSTITUTE FOR ESTHETICIANS Skincare manufacturer Le Mieux Cosmetics has opened the Bielle Institute. The 5,000-square-foot facility, located in Pasadena, California, will offer training for estheticians on antiaging skincare products and how to integrate them with a variety of devices and facial techniques. The two-story Institute will also host private events. "Le Mieux's audience has really grown over the past few years, and I felt it was time to establish a formal environment in which to share knowledge about Le Mieux products, ingredients and facial techniques," says Janel Luu, CEO of Le Mieux Cosmetics. "We can now welcome guests from all over the world to a beautiful and relaxed setting featuring luxurious, minimal, contemporary décor to participate in educational seminars and events." DERMATOLOGISTONCALL LAUNCHES MOBILE APPLICATION Iagnosis, in partnership with Newton Consulting, has launched a mobile platform for its online dermatology care site, dermatologistoncall.com. The site offers online access to board-certified dermatologists. Patients create a private and secure account where they can submit photographs and descriptions of their condition and receive a response from a dermatologist within three business days. The visit concludes with the delivery of a treatment plan containing the patient's history, current condition and diagnosis by the dermatologist, which may include a recommendation for an in-office visit, if necessary. Required prescriptions are sent electronically to the patient's pharmacy. "The mobile application will enable our patients to upload diagnostic pictures from their smart phones in a very seamless, fun and intuitive manner," said Scott Focer, COO of Iagnosis. "Additionally, the mobile app will facilitate direct messaging between dermatologists and their patients as a follow-up to their diagnosis, treatment and counsel."

Articles in this issue

Links on this page

Archives of this issue

view archives of Medesthetics - NOV-DEC 2013